Think Investments LP Humanigen, Inc Transaction History

Think Investments LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.93 - $17.83 $11.1 Million - $33.4 Million	-1,876,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.54 - $22.74 $3.23 Million - $5.42 Million	238,192 Added 14.54%	1,876,000 $32.6 Million
Q1 2021 May 17, 2021	BUY	$12.91 - $23.83 $3.87 Million - $7.15 Million	300,000 Added 22.42%	1,637,808 $31.3 Million
Q3 2020 Nov 16, 2020	BUY	$8.0 - $28.5 $10.7 Million - $38.1 Million	1,337,808 New	1,337,808 $14.2 Million

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Think Investments LP, based on Form 13F filings with the SEC.

Stay updated on Think Investments LP with notifications on news.